Xinyan Tracy Cui Named Distinguished Professor of Bioengineering
In recognition of her pioneering research, outstanding mentorship, and professional achievements, Xinyan (Tracy) Cui has been named Distinguished Professor of Bioengineering at the University of Pittsburgh.
“I’m deeply honored and humbled,” Cui said. “I am incredibly grateful for the support from the department, the Swanson School, and the University. This recognition belongs to the students, postdocs, collaborators, and colleagues who have been part of this work with me for more than two decades.”
A Distinguished Professorship honors extraordinary, internationally recognized scholarly attainment and is the highest honor that the University confers upon faculty members. Recognized for her research in neural engineering, Cui’s Neural Tissue Electrode Interface & Neural Tissue Engineering Laboratory develops implantable devices that record from, stimulate, and deliver drugs to the nervous system, with the goal of restoring lost neurological function or modulating neural activity to treat disease.
“The biggest obstacle in our field is that the implant and the body actively work against each other, so these devices lose function over time,” Cui said. “Our group studies these interactions directly and uses what we learn to design better materials and devices, including soft conducting polymers, biomimetic coatings, on-demand drug release systems, and flexible multimodal microelectrodes that can record brain activity and sense neurotransmitters simultaneously.”
Cui’s path began at Tsinghua University in Beijing, China, where she studied polymer materials and chemical engineering and earned an MS in biophysics. During her doctoral studies at the University of Michigan, Cui pioneered conductive polymer coatings for neural electrodes, which dramatically improved how well electrodes communicate with neural tissue. Cui arrived at the University of Pittsburgh in 2003 as the Department of Bioengineering’s first neural engineering hire, at a time when the field was just beginning to take root.
“With start-up support and external funding, I built my lab and took on the central problem of how neural tissue and devices interact.” Cui said. “In 2004, I co-founded the Neural Engineering PhD track with Dr. Andrew Schwartz, and it has since grown to more than 40 affiliated faculty and has trained more than 100 PhD students.”
Alongside her research, Cui counts the people she has trained among her proudest accomplishments. She has mentored more than 50 undergraduates, dozens of PhD students and postdocs, and several now-independent faculty. She has built on her early work with a comprehensive, multimodal approach to understanding implant-tissue interactions, combining in vivo imaging, electrophysiology, molecular biology, electrochemistry, and materials characterization. She’s also a co-founder of Vanish Therapeutics, a company developing bioresorbable, non-surgical nerve stimulators for opioid-free pain relief.
“I want to bring our technology to researchers and patients,” Cui said. “Some of our biocompatible coatings and neurotransmitter sensors have shown great results in large animal testing, and we are looking for the best way for dissemination or clinical translation.”
Cui has received more than 17,000 citations for her publications and holds nine patents, two of which have been licensed to industry. Her honors include Fellow of the American Institute for Medical and Biological Engineering (AIMBE), Fellow of the Royal Society of Chemistry, Senior Member of the National Academy of Innovators, a Carnegie Science Emerging Female Scientist Award, a NSF CAREER Award, and the Wallace Coulter Translational Research Career Award.
“Being a Distinguished Professor is an honor and also a responsibility,” Cui said. “I want to keep advancing neural engineering, keep mentoring the next generation, and push our discoveries from the bench to the bedside.”